FR2265390B1 - - Google Patents

Info

Publication number
FR2265390B1
FR2265390B1 FR7509298A FR7509298A FR2265390B1 FR 2265390 B1 FR2265390 B1 FR 2265390B1 FR 7509298 A FR7509298 A FR 7509298A FR 7509298 A FR7509298 A FR 7509298A FR 2265390 B1 FR2265390 B1 FR 2265390B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7509298A
Other versions
FR2265390A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3608074A external-priority patent/JPS5833236B2/ja
Priority claimed from JP4057774A external-priority patent/JPS5729473B2/ja
Priority claimed from JP4113074A external-priority patent/JPS5729476B2/ja
Priority claimed from JP4151574A external-priority patent/JPS5729475B2/ja
Priority claimed from JP4151674A external-priority patent/JPS5729477B2/ja
Priority claimed from JP4256874A external-priority patent/JPS5833237B2/ja
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of FR2265390A1 publication Critical patent/FR2265390A1/fr
Application granted granted Critical
Publication of FR2265390B1 publication Critical patent/FR2265390B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
FR7509298A 1974-03-28 1975-03-25 Expired FR2265390B1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP3608074A JPS5833236B2 (ja) 1974-03-28 1974-03-28 ７−（ アルフア − チカンアミノアルカンアミド ）−３− チカン −３− セフエム −４− カルボンサンユウドウタイノ セイゾウホウ
JP4057774A JPS5729473B2 (fr) 1974-04-09 1974-04-09
JP4113074A JPS5729476B2 (fr) 1974-04-10 1974-04-10
JP4151574A JPS5729475B2 (fr) 1974-04-11 1974-04-11
JP4151674A JPS5729477B2 (fr) 1974-04-11 1974-04-11
JP4256874A JPS5833237B2 (ja) 1974-04-15 1974-04-15 ７−（ アルフア− − チカンアミノアルカンアミド ）−３− チカン −３− セフエム −４− カルボンサンユウドウタイノ セイホウ

Publications (2)

Publication Number Publication Date
FR2265390A1 FR2265390A1 (fr) 1975-10-24
FR2265390B1 true FR2265390B1 (fr) 1978-07-28

Family

ID=27549794

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7509298A Expired FR2265390B1 (fr) 1974-03-28 1975-03-25

Country Status (4)

Country Link
US (2) US4039536A (fr)
DE (1) DE2512284A1 (fr)
FR (1) FR2265390B1 (fr)
GB (1) GB1488591A (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2512284A1 (de) * 1974-03-28 1975-10-09 Fujisawa Pharmaceutical Co Cephalosporansaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
US4091217A (en) * 1974-05-28 1978-05-23 Toshiyasu Ishimaru 7-((5'-N-Methylthioacetamido)-adipoamido)cephalosporin derivatives
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
JPS5760345B2 (fr) * 1974-12-19 1982-12-18 Takeda Chemical Industries Ltd
US4183925A (en) * 1975-03-27 1980-01-15 Pfizer Inc. 7-Aminophenylacetamido-Δ3 -cephem antibacterial agents and method of use
US4171362A (en) * 1975-10-30 1979-10-16 Smithkline Corporation 7-Acylamino-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins antibacterial compositions containing them and methods of treating bacterial infections with them
US4171433A (en) * 1975-10-30 1979-10-16 Smithkline Corporation 7-Amino-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporin intermediates for preparing 7-acylamino cephalosporins
US4171368A (en) * 1975-10-30 1979-10-16 Smithkline Corporation 7-Acylamino-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them
GB1579532A (en) * 1976-05-21 1980-11-19 Farmaceutici Italia Cephalosporins
DE2724073A1 (de) * 1976-06-03 1977-12-22 Fujisawa Pharmaceutical Co 3,7-disubstituierte 3-cephem-4- carbonsaeuren und sie enthaltende pharmazeutische zubereitungen
CH634848A5 (de) * 1976-08-17 1983-02-28 Fujisawa Pharmaceutical Co Verfahren zur herstellung neuer 7-(n-substituierter 2-phenylglycinamido)-3-substituierte-3-cephem-4-carbonsaeuren.
JPS5874680A (ja) * 1981-10-01 1983-05-06 Kyowa Hakko Kogyo Co Ltd β−ラクタム化合物
US4576937A (en) * 1984-02-29 1986-03-18 Smithkline Beckman Corporation 7-D-Mandelamido-3(1-sulfomethyltetrazol-5-yl)thiomethyl-3-cephem-4-carboxylic acid monosodium salt
IT1265061B1 (it) * 1993-08-06 1996-10-28 Dompe Spa Valilamidi di 7alfa-amino-1, 1-dioxo-cefem

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3222362A (en) * 1961-08-23 1965-12-07 Lilly Co Eli Arylaminoalkyl cephalosporins
FR1438747A (fr) * 1965-06-21 1966-05-13 Acides (pyridine-carbonamido)-7 céphalosporaniques
US3592812A (en) * 1968-12-06 1971-07-13 American Home Prod 7-(1-aminocycloalkylcarboxamido) cephalosporanic acids and related compounds
US3673183A (en) * 1969-11-17 1972-06-27 Squibb & Sons Inc {60 -ureidocephalosporanic acid compounds
US3867380A (en) * 1971-02-18 1975-02-18 Smithkline Corp 3-Heterocyclic thiomethylcephalosporins
US3796801A (en) * 1971-11-04 1974-03-12 Smithkline Corp Method of combating enterobacter infections
BE793191A (fr) * 1971-12-28 1973-06-22 Toyama Chemical Co Ltd Procede pour produire des acides 7-acylamido-3-cephem-4- carboxyliques
US3799923A (en) * 1972-01-03 1974-03-26 Fujisawa Pharmaceutical Co 3-thiolated cephalosporin derivatives and production of same
US3840531A (en) * 1972-03-21 1974-10-08 Lilly Co Eli Process for preparing 7-(alpha-hydroxy-alpha-phenyl)acetamido-3-(1-methyl-1h-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid and derivatives thereof
US3966718A (en) * 1973-01-18 1976-06-29 Beecham Group Limited 7-β-Acylamino-ceph-3-ems and salts and esters therefor
DE2512284A1 (de) * 1974-03-28 1975-10-09 Fujisawa Pharmaceutical Co Cephalosporansaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
GB1505345A (en) * 1974-04-10 1978-03-30 Beecham Group Ltd Cephalosporins

Also Published As

Publication number Publication date
GB1488591A (en) 1977-10-12
FR2265390A1 (fr) 1975-10-24
US4039536A (en) 1977-08-02
DE2512284A1 (de) 1975-10-09
US4252952A (en) 1981-02-24

Similar Documents

Publication Publication Date Title
JPS50130044A (fr)
JPS50125388A (fr)
JPS50140189A (fr)
JPS50155815A (fr)
JPS50144410A (fr)
AR199089A1 (fr)
AU495844B2 (fr)
JPS5122205U (fr)
AU7474374A (fr)
JPS50127476U (fr)
JPS50145280U (fr)
JPS50153709A (fr)
BG26358A3 (fr)
CH573303A5 (fr)
BG20665A1 (fr)
BG20670A1 (fr)
BG20724A1 (fr)
BG20849A1 (fr)
BG21661A1 (fr)
BG21791A1 (fr)
BG22011A1 (fr)
BG22387A3 (fr)
BG22667A1 (fr)
BG26192A3 (fr)
BG20186A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse